New Products
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 232251 | Brepocitinib ( PF-06700841 ) | 1883299-62-4 | ≧98.0% | _1883299-62-4.png) |
| Brepocitinib 是一种潜在的 TYK2 和 JAK1双重选择性抑制剂，IC50 分别为 | ||||
| 20460 | Ro5-3335 | 30195-30-3 | ≧98.0% |  |
| Ro5-3335 是一种亲脂性小分子 RUNX1 抑制剂。 | ||||
| 233901 | RRX-001 | 925206-65-1 | ≧98.0% |  |
| RRx-001 是一种高选择性 NLRP3 抑制剂，具有血管正常化和肿瘤相关的 | ||||
| 20474 | Tinlarebant ( LBS-008 ) | 1821327-95-0 | ≧98.0% |  |
| Tinlarebant (LBS-008) 是一种视黄醇结合蛋白 4 (RBP4) 的小分子抑制剂。 | ||||
| 230401 | 苯丁酸甘油酯 | 611168-24-2 | ≧98.0% | .png) |
| Glycerol phenylbutyrate 是 sigma-2 (σ2) 受体的一个配体，其 pKi 值 | ||||
| 230403 | (R,S)-BI 1015550 | 1423719-27-0 | ≧98.0% | -BI_1015550_1423719-27-0.png) |
| BI 1015550 is a novel PDE4 inhibitor showing a preferential enzymatic inhibition of P | ||||
| 237072 | AZD0095 | 2750001-23-9 | ≧98.0% |  |
| AZD0095 is a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. | ||||
| 20508 | AZD5991 | 2143061-81-6 | ≧98.0% |  |
| AZD-5991 是一种有效的选择性 Mcl-1 抑制剂。 | ||||
| 20511 | PDD4091 | 1373651-41-2 | ≧98.0% |  |
| PDD4091 是一种新颖的G6PD抑制剂。 | ||||
| 20512 | BDTX-1535 | 2607829-38-7 | ≧98.0% |  |
| BDTX-1535 是一种突变选择性、不可逆的第四代 EGFR 抑制剂。 | ||||
| 20514 | NMS-293 ( NMS-P293 ) | 1606996-12-6 | ≧98.0% |  |
| NMS-293 是 Nerviano Medical Sciences 处于早期临床开发阶段的 PARP-1 抑制 | ||||
| 20576 | STX-721 | 2765525-82-2 | ≧98.0% |  |
| STX-721 is a next-generation, orally delivered therapy, designed with potential best- | ||||